Item(by='8bitsrule', descendants=None, kids=None, score=None, time=1611366052, title=None, item_type='comment', url=None, parent=25876738, text='Paper&#x27;s DOI:  <a href="https:&#x2F;&#x2F;doi.org&#x2F;10.1371&#x2F;journal.ppat.1009212" rel="nofollow">https:&#x2F;&#x2F;doi.org&#x2F;10.1371&#x2F;journal.ppat.1009212</a><p>Wayback URL: <a href="https:&#x2F;&#x2F;web.archive.org&#x2F;web&#x2F;20210122215919&#x2F;https:&#x2F;&#x2F;journals.plos.org&#x2F;plospathogens&#x2F;article?id=10.1371%2Fjournal.ppat.1009212" rel="nofollow">https:&#x2F;&#x2F;web.archive.org&#x2F;web&#x2F;20210122215919&#x2F;https:&#x2F;&#x2F;journals....</a><p>Summary conclusion: &quot;Finally, we show that combinations of hydroxychloroquine and a clinically tested TMPRSS2 inhibitor work together to effectively inhibit SARS-CoV-2 entry. Thus TMPRSS2 expression on physiologically relevant SARS-CoV-2 target cells may bypass the antiviral activities of hydroxychloroquine, and explain its lack of in vivo efficacy... &quot;')